Vir Biotechnology, Inc. Common Stock (VIR) is a publicly traded Healthcare sector company. As of October 1, 2026, VIR trades at $11.56 with a market cap of $1.80B and a P/E ratio of -5.99. VIR moved +0.81% today. Year to date, VIR is +88.22%; over the trailing twelve months it is +95.80%. Its 52-week range spans $4.16 to $11.94. Analyst consensus is strong buy with an average price target of $21.29. Rallies surfaces VIR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VIR financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VIR recently traded at $11.56. Market cap is $1.80B. P/E ratio is -5.99. Revenue is $303.23M.
| Metric | Value |
|---|---|
| Price | $11.56 |
| Market Cap | $1.80B |
| P/E Ratio | -5.99 |
| EPS | $-1.84 |
| Dividend Yield | 0.03% |
| 52-Week High | $11.94 |
| 52-Week Low | $4.16 |
| Volume | 285.32K |
| Avg Volume | 0 |
| Revenue (TTM) | $303.23M |
| Net Income | $-251.68M |
| Gross Margin | 0.00% |
8 analysts cover VIR: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $21.29.